BPC 157 reduces various arrhythmias (i.e., potassium overdose-induced hyperkalemia (Barisic et al., 2013), digitalis (Balenovic et al., 2009), neuroleptics (i.e., prolonged QTc-intervals that may also be centrally related) (Strinic et al., 2017), bupivacaine (Zivanovic-Posilovic et al., 2016), lidocaine (Lozic et al., 2020), and succinylcholine (Stambolija et al., 2016))
AdvaCare Pharma, a US-owned pharmaceutical company, is a manufacturer of Vitamin B12 Injection with GMP-compliant manufacturing facilities located worldwide
This compound is part of our Research Peptides category and is supplied for use in controlled laboratory and in vitro research environments
Reduced inflammation and improved mobility in 2 weeks
Lumenal lipid metabolism: implications for lipoprotein assembly